Insights for revenue cycle leaders

Medicare's PAMA lab pricing overhaul creates unexpected revenue cycle complexity for surgery centers and hospital outpatient departments.

A buyer's guide to ambulatory billing software in 2026: how to choose between EMR-native, standalone PM, outsourced RCM, and agentic AI tools.

The due diligence questions that reveal whether a healthcare innovation will deliver ROI or become expensive shelfware.

HHS hearings reveal coming Medicare payment changes that could reshape ASC margins and surgical volume economics.

How to turn payer agreements into rules your billing team can use, plus what to demand from contract analysis software in 2026.

Seven RCM platforms compared for ASCs and outpatient practices: first-pass rates, deployment timelines, pricing, and specialty fit.

H-1B visa fees create unexpected budget drains for healthcare organizations already facing workforce shortages and margin pressure.

The 2.48% rate bump masks fundamental changes to risk scoring that could upend how MA plans negotiate with providers.

Ten risk-reduction strategies finance leaders can use to evaluate healthcare innovation investments and protect margins.